Survivors of childhood central nervous system cancer show affected self-identity
the ONA take:
According to a new study published in the journal Neuro-Oncology, researchers from the Korlinska Institutet in Sweden have found that patients treated for central nervous system (CNS) cancer during childhood or adolescence can display altered self-perception and self-identify later in adulthood.
For the study, researchers followed 700 adult survivors of childhood CNS cancer who were diagnosed between 1992 and 2001. Researchers compared these patients to a control group from the general population. They studied how the cancer, the treatment, and the aftermath affected the patient's health, function, and psychological identity. Psychological identity includes their self-perception and self-esteem, which researchers assessed using a standardized self-report questionnaire.
Results showed that all components of having CNS cancer affected patients' psychological identity later in adulthood. Researchers found survivors more often had a negative self-perception compared with the control group.
For example, in the context of work and friends, 22% and 30% of survivors had a negative self-perception, respectively, while 8% and 17% of the control group had a negative self-perception, respectively.
Results of self-perception were similar across both groups in the context of family. Findings suggest that more preventative measures are necessary to aid in long-term personality development.
Patients treated for CNS cancer during childhood can display altered self-perception later in adulthood.
The study followed 700 adult survivors diagnosed 1992-2001 with a childhood CNS tumour. The study group covered all adult brain tumour survivors in Sweden at the time of start of study. Patients were compared with a control group selected from the general population.
Sign Up for Free e-newsletters
- Is Radioimmunotherapy a Path Forward for Melanoma?
- FDA Approves Mogamulizumab-kpkc for Rare Subtypes of Non-Hodgkin Lymphoma
- New PDL1 Inhibitors for Non-small Cell Lung Cancer: Focus on Pembrolizumab
- Intensive Chemotherapy May Not Be Effective in MDS or AML After MDS
- ASCO Endorses SIO Guideline for Integrative Therapies in Breast Cancer
- NCCIH HerbList App Launched to Provide Information on Herbal Products
- Metformin Use May Improve Survival Outcomes in Bladder Cancer
- Higher Vitamin D Levels Associated With Lower Breast Cancer Risk
- Nurse-Led Program Improves Health, Financial Outcomes in Outpatient Chemotherapy
- Seeking Reliable Information on Herbal Products
- Disparities Remain in Prevalence of Cancer Screening Tests
- Hope, Gratitude, and Spirituality: What They Mean to Cancer Patients
- FDA, EU Approvals Sought for Split Dose Regimen of Daratumumab for Multiple Myeloma
- 8 Hours of Bedrest May Be Ideal After Intrathecal Chemotherapy in Hematologic Cancers
- Combined Digital Screening Best for Detecting Breast Cancers
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|